Dose-adjusted EPOCH chemotherapy with bortezomib and raltegravir for human T-cell leukemia virus-associated adult T-cell leukemia lymphoma

L. Ratner, D. Rauch, H. Abel, B. Caruso, A. Noy, S. K. Barta, S. Parekh, Juan Carlos Ramos, R. Ambinder, A. Phillips, J. Harding, H. H. Baydoun, X. Cheng, S. Jacobson

Research output: Contribution to journalLetter

13 Citations (Scopus)
Original languageEnglish (US)
Pages (from-to)e408
JournalBlood Cancer Journal
Volume6
DOIs
StatePublished - Mar 25 2016

Fingerprint

Antineoplastic Combined Chemotherapy Protocols
HTLV-I Infections
Deltaretrovirus
Adult T Cell Leukemia Lymphoma
Human T-lymphotropic virus 1
Vincristine
Etoposide
Prednisone
Doxorubicin
Cyclophosphamide
Drug Therapy
Bortezomib
Raltegravir Potassium

ASJC Scopus subject areas

  • Hematology
  • Oncology

Cite this

Dose-adjusted EPOCH chemotherapy with bortezomib and raltegravir for human T-cell leukemia virus-associated adult T-cell leukemia lymphoma. / Ratner, L.; Rauch, D.; Abel, H.; Caruso, B.; Noy, A.; Barta, S. K.; Parekh, S.; Carlos Ramos, Juan; Ambinder, R.; Phillips, A.; Harding, J.; Baydoun, H. H.; Cheng, X.; Jacobson, S.

In: Blood Cancer Journal, Vol. 6, 25.03.2016, p. e408.

Research output: Contribution to journalLetter

Ratner, L, Rauch, D, Abel, H, Caruso, B, Noy, A, Barta, SK, Parekh, S, Carlos Ramos, J, Ambinder, R, Phillips, A, Harding, J, Baydoun, HH, Cheng, X & Jacobson, S 2016, 'Dose-adjusted EPOCH chemotherapy with bortezomib and raltegravir for human T-cell leukemia virus-associated adult T-cell leukemia lymphoma', Blood Cancer Journal, vol. 6, pp. e408. https://doi.org/10.1038/bcj.2016.21
Ratner, L. ; Rauch, D. ; Abel, H. ; Caruso, B. ; Noy, A. ; Barta, S. K. ; Parekh, S. ; Carlos Ramos, Juan ; Ambinder, R. ; Phillips, A. ; Harding, J. ; Baydoun, H. H. ; Cheng, X. ; Jacobson, S. / Dose-adjusted EPOCH chemotherapy with bortezomib and raltegravir for human T-cell leukemia virus-associated adult T-cell leukemia lymphoma. In: Blood Cancer Journal. 2016 ; Vol. 6. pp. e408.
@article{67667832be734efb93c679655c8a3ce6,
title = "Dose-adjusted EPOCH chemotherapy with bortezomib and raltegravir for human T-cell leukemia virus-associated adult T-cell leukemia lymphoma",
author = "L. Ratner and D. Rauch and H. Abel and B. Caruso and A. Noy and Barta, {S. K.} and S. Parekh and {Carlos Ramos}, Juan and R. Ambinder and A. Phillips and J. Harding and Baydoun, {H. H.} and X. Cheng and S. Jacobson",
year = "2016",
month = "3",
day = "25",
doi = "10.1038/bcj.2016.21",
language = "English (US)",
volume = "6",
pages = "e408",
journal = "Blood Cancer Journal",
issn = "2044-5385",
publisher = "Nature Publishing Group",

}

TY - JOUR

T1 - Dose-adjusted EPOCH chemotherapy with bortezomib and raltegravir for human T-cell leukemia virus-associated adult T-cell leukemia lymphoma

AU - Ratner, L.

AU - Rauch, D.

AU - Abel, H.

AU - Caruso, B.

AU - Noy, A.

AU - Barta, S. K.

AU - Parekh, S.

AU - Carlos Ramos, Juan

AU - Ambinder, R.

AU - Phillips, A.

AU - Harding, J.

AU - Baydoun, H. H.

AU - Cheng, X.

AU - Jacobson, S.

PY - 2016/3/25

Y1 - 2016/3/25

UR - http://www.scopus.com/inward/record.url?scp=85013692945&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85013692945&partnerID=8YFLogxK

U2 - 10.1038/bcj.2016.21

DO - 10.1038/bcj.2016.21

M3 - Letter

C2 - 27015285

AN - SCOPUS:85013692945

VL - 6

SP - e408

JO - Blood Cancer Journal

JF - Blood Cancer Journal

SN - 2044-5385

ER -